United States · FDA National Drug Code directory
NITROFURANTOIN (monohydrate/macrocrystals)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-884_2b480a86-eebf-c37e-e063-6394a90ae54b
- Product NDC
- 76420-884
- Form
- CAPSULE
- Composition / generic term
- Nitrofurantoin (monohydrate/macrocrystals)
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220222
- Source listing expiry
- 20261231
Source-listed ingredients
- NITROFURANTOIN MONOHYDRATE — 75 mg/1
- NITROFURANTOIN — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE in 1 BOTTLE (76420-884-00) · 76420-884-00
- 100 CAPSULE in 1 BOTTLE (76420-884-01) · 76420-884-01
- 7 CAPSULE in 1 BOTTLE (76420-884-07) · 76420-884-07
- 10 CAPSULE in 1 BOTTLE (76420-884-10) · 76420-884-10
- 12 CAPSULE in 1 BOTTLE (76420-884-12) · 76420-884-12
- 14 CAPSULE in 1 BOTTLE (76420-884-14) · 76420-884-14
- 20 CAPSULE in 1 BOTTLE (76420-884-20) · 76420-884-20
- 28 CAPSULE in 1 BOTTLE (76420-884-28) · 76420-884-28
- 30 CAPSULE in 1 BOTTLE (76420-884-30) · 76420-884-30
- 60 CAPSULE in 1 BOTTLE (76420-884-60) · 76420-884-60
- 90 CAPSULE in 1 BOTTLE (76420-884-90) · 76420-884-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →